In vitro and in vivo anti-herpes simplex virus activity of monogalactosyl diacylglyceride from Coccomyxa sp. KJ

• Published in: PloS one 2019-07, Vol.14 (7), p.e0219305
• Main Authors: Hayashi, Kyoko, Lee, Jung-Bum, Atsumi, Kinya, Kanazashi, Mana, Shibayama, Tamaki, Okamoto, Kazumasa, Kawahara, Toshio, Hayashi, Toshimitsu
• Format: Article
• Language: English
• Subjects: Antiviral agents; Bioassay; Care and treatment; Citrus; Electron microscopy; Fatty acids; Genetic aspects; Genital herpes; Green algae; Herpes simplex; Herpes simplex virus; Herpesvirus infections; Linolenic acids; Microscopy; MP3 players; Novels; Omega 3 fatty acids; Risk factors; Unsaturated fatty acids
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0219305

A monogalactosyl diacylglyceride (MGDG) was isolated as an antiviral component from Coccomyxa sp. KJ (IPOD FERM BP-22254) via bioassay-guided fractionation. [alpha]-Linolenic acid (C18:3) and 7,10,13-hexadecatrienoic acid (C16:3) accounted for approximately 72% and 23%, respectively, of the MGDG total fatty acids of the MGDG. The MGDG showed virucidal activity against herpes simplex virus type 2 (HSV-2), a pathogen that causes genital herpes. Physical changes in HSV-2 shape were observed after treatment with MGDG, including a decrease in particle size, and possible damage to the viral envelope, as assessed using electron microscopy. In accordance with the morphological findings, virus particles lost their ability to bind to host cells. HSV-2 treated with high concentrations of MGDG resulted in no pathogenicity in an animal model, indicating that MGDG exhibits irreversible virucidal activity against HSV-2 particles. In the animal model of HSV-2-induced genital herpes, intravaginally administered MGDG exerted a prophylactic effect by suppressing viral yields in the genital cavity and formation of herpetic lesions, resulting in a higher survival rate in treated mice than control mice administered solvent. Thus, MGDG offers a novel prophylactic option against HSV infections.